Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo

British Journal of Cancer

Volumn 101, Issue 8, 2009, Pages 1307-1315

  Andersson, Y ^a   Engebraaten, O ^a,b   Fodstad, O ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Apoptosis; Breast cancer; Cyclosporin; Immunotoxin; Metastasis model

Indexed keywords

CYCLOSPORIN A; IMMUNOTOXIN; PSEUDOMONAS EXOTOXIN; RAPAMYCIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL VIABILITY; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS INHIBITION; NICK END LABELING; NONHUMAN; NUDE RAT; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SURVIVAL TIME; TREATMENT RESPONSE; UTERINE CERVIX CANCER; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CYCLOSPORINE; DRUG SYNERGISM; FEMALE; HUMANS; IMMUNOTOXINS; MALE; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; RATS; SIROLIMUS; TACROLIMUS;

EID: 70349961520     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605312     Document Type: Article

References (30)

1. Andersson Y, Juell S, Fodstad O (2004) Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin. Int J Cancer 112: 475-483
2. Andersson Y, Le H, Juell S, Fodstad O (2006) AMP-activated protein kinase protects against anti-epidermal growth factor receptor-Pseudomonas exotoxin A immunotoxin-induced MA11 breast cancer cell death. Mol Cancer Ther 5: 1050-1059
3. Arceci RJ, Stieglitz K, Bierer BE (1992) Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood 80: 1528-1536
4. Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55
5. Ciechomska I, Legat M, Golab J, Wesolowska A, Kurzaj Z, Mackiewicz A, Kaminska B (2005) Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies. Int J Cancer 117: 59-67
6. Ciechomska I, Pyrzynska B, Kazmierczak P, Kaminska B (2003) Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells. Oncogene 22: 7617-7627
7. Clipstone NA, Crabtree GR (1992) Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357: 695-697
8. Engebraaten O, Fodstad O (1999) Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats. Int J Cancer 82: 219-225
9. Engebraaten O, Sivam G, Juell S, Fodstad O (2000) Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats. Int J Cancer 88: 970-976
10. Frei UA, Neumayer HH, Buchholz B, Niese D, Mueller EA (1998) Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclo-sporine in renal transplant patients. International Sandimmun Neoral Study Group. Transplantation 65: 1455-1460
11. Godal A, Kumle B, Pihl A, Juell S, Fodstad O (1992) Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations. Int J Cancer 52: 631-635
12. Hjortland GO, Bjornland K, Pettersen S, Garman-Vik SS, Emilsen E, Nesland JM, Fodstad O, Engebraaten O (2003) Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1. Clin Exp Metastasis 20: 301-309
13. Hussaini IM, Brown MD, Karns LR, Carpenter J, Redpath GT, Gonias SL, Vandenberg SR (1999) Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes. Glia 25: 71-84
14. Koo J (1998) A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, neoral and sandimmun, in patients with severe psoriasis. OLP302 Study Group. Br J Dermatol 139: 88-95
15. Kreitman RJ (2003) Recombinant toxins for the treatment of cancer. Curr Opin Mol Ther 5: 44-51
16. Ledermann JA, Begent RH, Bagshawe KD, Riggs SJ, Searle F, Glaser MG, Green AJ, Dale RG (1988) Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A. Br J Cancer 58: 654-657
17. Lee CT, Huynh VM, Lai LW, Lien YH (2002) Cyclosporine A-induced hypercalciuria in calbindin-D28k knockout and wild-type mice. Kidney Int 62: 2055-2061
18. Levy G, Burra P, Cavallari A, Duvoux C, Lake J, Mayer AD, Mies S, Pollard SG, Varo E, Villamil F, Johnston A (2002) Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation 73: 953-959
19. Lund T, Stokke T, Olsen OE, Fodstad O (2005) Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein BimEL and induces apoptosis. Br J Cancer 92: 1773-1781
20. Micci F, Teixeira MR, Heim S (2001) Complete cytogenetic characterization of the human breast cancer cell line MA11 combining G-banding, comparative genomic hybridization, multicolor fluorescence in situ hybridization, RxFISH, and chromosome-specific painting. Cancer Genet Cytogenet 131: 25-30
21. Mueller BM, Romerdahl CA, Trent JM, Reisfeld RA (1991) Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor. Cancer Res 51: 2193-2198
22. Palomero J, Galan AI, Munoz ME, Tunon MJ, Gonzalez-Gallego J, Jimenez R (2001) Effects of aging on the susceptibility to the toxic effects of cyclosporin A in rats. Changes in liver glutathione and antioxidant enzymes. Free Radic Biol Med 30: 836-845
23. Pyrzynska B, Serrano M, Martinez AC, Kaminska B (2002) Tumor suppressor p53 mediates apoptotic cell death triggered by cyclosporin A. J Biol Chem 277: 14102-14108
24. Rye PD, Norum L, Olsen DR, Garman-Vik S, Kaul S, Fodstad O (1996) Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11. Int J Cancer 68: 682-687
25. Sandvig K, Olsnes S (1982) Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin into cells. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles. J Biol Chem 257: 7504-7513
26. Sliwa M, Markovic D, Gabrusiewicz K, Synowitz M, Glass R, Zawadzka M, Wesolowska A, Kettenmann H, Kaminska B (2007) The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A. Brain 130: 476-489
27. Soussi T, Wiman KG (2007) Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 12: 303-312 (Pubitemid 47539312)
28. Vakeva L, Reitamo S, Pukkala E, Sarna S, Ranki A (2008) Long-term follow-up of cancer risk in patients treated with short-term cyclosporine. Acta Derm Venereol 88: 117-120
29. Weiden PL, Wolf SB, Breitz HB, Appelbaum JW, Seiler CA, Mallett R, Bjorn MJ, Su FM, Fer MF, Salk D (1994) Human anti-mouse antibody suppression with cyclosporin A. Cancer 73: 1093-1097
30. Weischer M, Rocken M, Berneburg M (2007) Calcineurin inhibitors and rapamycin: cancer protection or promotion? Exp Dermatol 16: 385-393